BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6284445)

  • 1. Severe hepatitis associated with ketoconazole therapy for chronic mucocutaneous candidiasis.
    Tkach JR; Rinaldi MG
    Cutis; 1982 May; 29(5):482-4. PubMed ID: 6284445
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.
    Horsburgh CR; Kirkpatrick CH
    Am J Med; 1983 Jan; 74(1B):23-9. PubMed ID: 6295149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis and ketoconazole therapy.
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1058-9. PubMed ID: 6271330
    [No Abstract]   [Full Text] [Related]  

  • 4. Ketoconazole in a case of chronic mucocutaneous candidiasis.
    Zachariae H; Laurberg G; Thestrup-Pedersen K
    Acta Derm Venereol; 1982; 62(1):87-9. PubMed ID: 6175153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketoconazole in the treatment of chronic mucocutaneous candidiasis secondary to autoimmune polyendocrinopathy-candidiasis syndrome.
    Appleboom TM; Flowers FP
    Cutis; 1982 Jul; 30(1):71-2. PubMed ID: 6288325
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatic dysfunction and ketoconazole therapy.
    Svejgaard E; Ranek L
    Ann Intern Med; 1982 Jun; 96(6 Pt 1):788-9. PubMed ID: 6283980
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy of chronic mucocutaneous candidiasis.
    Rosenblatt HM; Stiehm ER
    Am J Med; 1983 Jan; 74(1B):20-2. PubMed ID: 6295148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial.
    Petersen EA; Alling DW; Kirkpatrick CH
    Ann Intern Med; 1980 Dec; 93(6):791-5. PubMed ID: 6255844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toxic hepatitis caused by ketoconazole].
    Ned Tijdschr Geneeskd; 1983 Jun; 127(25):1114-5. PubMed ID: 6308481
    [No Abstract]   [Full Text] [Related]  

  • 10. [Toxic hepatitis during the administration of ketoconazole (Nizoral)].
    Kramer NJ; Montnor LP; Berghuis PH
    Ned Tijdschr Geneeskd; 1983 Feb; 127(8):343-4. PubMed ID: 6300703
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatitis during the administration of ketoconazole (Nizoral)].
    van Dijke CP
    Ned Tijdschr Geneeskd; 1983 Feb; 127(8):339-41. PubMed ID: 6300701
    [No Abstract]   [Full Text] [Related]  

  • 12. [Toxic hepatitis caused by ketoconazole (Nizoral)].
    Boëtius G; Peeters JP; Peters JH
    Ned Tijdschr Geneeskd; 1983 Feb; 127(8):341-3. PubMed ID: 6300702
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential and problems with ketoconazole.
    Graybill JR
    Am J Med; 1983 Jan; 74(1B):86-90. PubMed ID: 6295157
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic mucocutaneous candidiasis treated with ketoconazole.
    Egere JU; Gugnani HC; Nzelibe FK
    East Afr Med J; 1982 Apr; 59(4):291-4. PubMed ID: 6291894
    [No Abstract]   [Full Text] [Related]  

  • 15. Ketoconazole treatment of chronic mucocutaneous candidiasis.
    Graybill JR; Herndon JH; Kniker WT; Levine HB
    Arch Dermatol; 1980 Oct; 116(10):1137-41. PubMed ID: 6252853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic mucocutaneous candidiasis with a serum-dependent neutrophil defect: response to ketoconazole.
    Kennedy CT; Valdimarsson H; Hay RJ
    J R Soc Med; 1981 Feb; 74(2):158-62. PubMed ID: 6259351
    [No Abstract]   [Full Text] [Related]  

  • 17. Intermittent ketoconazole therapy of chronic mucocutaneous candidiasis in childhood.
    Fanconi S; Seger R; Joller P; Issler C; Schär G
    Eur J Pediatr; 1982 Nov; 139(3):176-80. PubMed ID: 6297913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial chronic mucocutaneous candidiasis successfully treated with oral ketoconazole.
    Morrison JG; Anderson R
    S Afr Med J; 1981 Feb; 59(7):237-9. PubMed ID: 6256921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hepatitis during ketoconazole therapy.
    Okumura H; Aramaki T; Satomura K; Iizuka K; Ohta M; Katsuta Y; Akaike M; Terada H; Kusunoki T
    Gastroenterol Jpn; 1983 Apr; 18(2):142-7. PubMed ID: 6303886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe chronic mucocutaneous candidiasis. Favourable response to oral therapy with ketoconazole.
    Williamson MM; Gordon RD
    Med J Aust; 1983 Mar; 1(6):276-8. PubMed ID: 6298584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.